RNAC
Cartesian Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.03
+2.16%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.02
- Revenue estimate
- $180.0K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.46
- EPS estimate
- -$0.88
- Revenue actual
- —
- Revenue estimate
- $179.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -13.5%
- Revenue beats (12Q)
- 7
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.88 | $0.46 | Beat 152.40% | — |
| Apr 30, 2026 | -$0.84 | -$1.46 | Miss -73.81% | $78.0K |
| Mar 9, 2026 | -$0.85 | -$1.38 | Miss -62.14% | $947.0K |
| Nov 6, 2025 | -$0.81 | -$1.38 | Miss -70.37% | $452.0K |
| Aug 7, 2025 | -$0.76 | $0.50 | Beat 165.79% | $298.0K |
| May 8, 2025 | -$0.61 | -$0.68 | Miss -11.48% | $1.1M |
| Mar 20, 2025 | -$0.78 | -$0.59 | Beat 24.36% | $759.0K |
| Nov 7, 2024 | -$0.78 | -$0.69 | Beat 11.54% | $387.0K |
| Aug 8, 2024 | -$1.07 | $0.54 | Beat 150.47% | $33.4M |
| Mar 7, 2024 | -$0.30 | -$2.40 | Miss -700.00% | $8.3M |
| Aug 17, 2023 | -$0.09 | -$0.07 | Beat 22.22% | $5.2M |
| Dec 31, 2020 | — | -$0.17 | — | $12.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026